The hepato-pancreatico-biliary (hpb) surgeries surgical devices market size has grown strongly in recent years. It will grow from $5.62 billion in 2025 to $5.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing incidence of liver and pancreatic diseases, expansion of specialized surgical centers, growing adoption of laparoscopic techniques, rising availability of advanced surgical instruments, improved surgeon training and expertise.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for robotic-assisted hpb surgeries, rising investments in high-definition visualization systems, expansion of minimally invasive oncology procedures, growing focus on precision and safety in complex surgeries, increasing adoption of integrated surgical platforms. Major trends in the forecast period include increasing adoption of advanced energy-based surgical devices, rising use of minimally invasive hpb procedures, growing integration of robotic and visualization systems, expansion of precision surgical instrumentation, enhanced focus on complex procedure safety.
The growing trend of medical tourism is expected to drive the expansion of the hepatic-pancreatic-biliary (HPB) surgical device market in the coming years. Medical tourism involves patients traveling to other countries to access specialized medical procedures that offer higher quality care, advanced technologies, and reduced waiting times. Demand for medical tourism is increasing as patients pursue affordable, high-precision surgical treatments at internationally accredited healthcare facilities. HPB surgical devices support this trend by enabling precise and minimally invasive interventions for disorders of the liver, pancreas, and bile ducts. For instance, in December 2023, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, healthcare expenditure in the United States increased by 4.1% in 2023 to reach $4.5 trillion, while spending on hospital care services grew by 2.2% in the same year, totaling $1.4 trillion. Therefore, the rise in medical tourism is contributing to the growth of the hepatic-pancreatic-biliary (HPB) surgery and surgical devices market.
Major companies operating in the hepato-pancreatico-biliary (HPB) surgeries surgical devices market are emphasizing technological advancements such as integrated fluorescence-guided ICG imaging, which enables real-time evaluation of tissue perfusion, vascular networks, and biliary anatomy to improve intraoperative accuracy and surgical results. Integrated fluorescence-guided ICG imaging utilizes Indocyanine Green dye combined with near-infrared visualization to allow surgeons to view anatomical details beyond the visible spectrum, supporting clearer identification of essential HPB structures during minimally invasive procedures. For instance, in February 2024, CMR Surgical, a UK-based surgical robotics company, introduced the vLimeLite fluorescence imaging system integrated into its Versius Plus robotic platform. The system provides dual visualization modes, including full-color overlay or greyscale, along with selectable ICG color options in green or cyan, enabling surgeons to assess blood flow, vessel integrity, and biliary anatomy with greater clarity during HPB surgical procedures.
In February 2023, Olympus Corporation, a Japan-based medical technology company, agreed to acquire Taewoong Medical Co., Ltd. for approximately $370 million. Through this acquisition, Olympus seeks to reinforce its gastrointestinal EndoTherapy portfolio by incorporating advanced gastrointestinal metallic stent technologies, expanding minimally invasive treatment options, and improving patient outcomes. Taewoong Medical Co., Ltd. is a Korea-based company specializing in the manufacture of gastrointestinal metallic stents and other minimally invasive GI therapeutic devices.
Major companies operating in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market are Johnson & Johnson Services Ltd., Medtronic Plc, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, BD CooperSurgical Inc., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Smith & Nephew plc, W.L. Gore & Associates Inc., Cook Medical Inc., CONMED Corporation, Richard Wolf GmbH, CooperSurgical Inc., Medi-Globe GmbH, Thompson Surgical Instruments Inc., Lotus Surgicals Pvt. Ltd., Hobbs Medical Inc., Medorah Meditek Pvt. Ltd.
North America was the largest region in the hepatic-pancreatic-biliary (HPB) surgical device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the HPB surgeries surgical devices market by increasing costs of imported electrosurgical systems, robotic components, visualization equipment, stents, and precision hand instruments used in complex procedures. Hospitals and specialty surgical centers in North America and Europe are most affected due to dependence on imported high-end surgical technologies, while Asia-Pacific faces increased manufacturing and export costs. These tariffs are raising capital investment requirements and slowing equipment upgrades. However, they are also driving localized manufacturing, regional assembly, and innovation in cost-optimized surgical device platforms.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report is one of a series of new reports that provides hepato-pancreatico-biliary (hpb) surgeries surgical devices market statistics, including hepato-pancreatico-biliary (hpb) surgeries surgical devices industry global market size, regional shares, competitors with a hepato-pancreatico-biliary (hpb) surgeries surgical devices market share, detailed hepato-pancreatico-biliary (hpb) surgeries surgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the hepato-pancreatico-biliary (hpb) surgeries surgical devices industry. This hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices are specialized instruments designed for cutting, dissecting, grasping, and suturing tissues in surgical procedures involving the liver (hepato-), pancreas (pancreatic-), and bile ducts (biliary). These devices play a crucial role in performing intricate procedures on these delicate organs.
The main products in the field of hepato-pancreatic-biliary (HPB) surgeries surgical devices include electrosurgery instruments, endoscopes, hand instruments, access instruments, stents, energy/vessel sealing devices, visualization and robotic surgical systems, surgical suture and stapler devices, and fluid management systems. Electrosurgery instruments utilize high-frequency, alternating electric current to generate heat in tissues, enabling various surgical procedures such as cutting, coagulating, desiccating, or fulgurating tissue. These devices find indications in the treatment of conditions such as liver cancer, pancreatic cancer, gallstones, bile duct cancer, cirrhosis, pancreatitis, and cholecystitis. They are commonly used in hospitals, specialty clinics, trauma centers, and ambulatory surgical centers.
The hepato-pancreatico-biliary (HPB) surgeries surgical devices market includes revenues earned by entities by liver surgeries, ultrasonic aspirators, liver retractors, and liver transplantation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepato-pancreatico-biliary (HPB) surgeries surgical devices market also includes sales of visualization and access instruments, trocars, energy devices, and ultrasonic scalpels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for robotic-assisted hpb surgeries, rising investments in high-definition visualization systems, expansion of minimally invasive oncology procedures, growing focus on precision and safety in complex surgeries, increasing adoption of integrated surgical platforms. Major trends in the forecast period include increasing adoption of advanced energy-based surgical devices, rising use of minimally invasive hpb procedures, growing integration of robotic and visualization systems, expansion of precision surgical instrumentation, enhanced focus on complex procedure safety.
The growing trend of medical tourism is expected to drive the expansion of the hepatic-pancreatic-biliary (HPB) surgical device market in the coming years. Medical tourism involves patients traveling to other countries to access specialized medical procedures that offer higher quality care, advanced technologies, and reduced waiting times. Demand for medical tourism is increasing as patients pursue affordable, high-precision surgical treatments at internationally accredited healthcare facilities. HPB surgical devices support this trend by enabling precise and minimally invasive interventions for disorders of the liver, pancreas, and bile ducts. For instance, in December 2023, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, healthcare expenditure in the United States increased by 4.1% in 2023 to reach $4.5 trillion, while spending on hospital care services grew by 2.2% in the same year, totaling $1.4 trillion. Therefore, the rise in medical tourism is contributing to the growth of the hepatic-pancreatic-biliary (HPB) surgery and surgical devices market.
Major companies operating in the hepato-pancreatico-biliary (HPB) surgeries surgical devices market are emphasizing technological advancements such as integrated fluorescence-guided ICG imaging, which enables real-time evaluation of tissue perfusion, vascular networks, and biliary anatomy to improve intraoperative accuracy and surgical results. Integrated fluorescence-guided ICG imaging utilizes Indocyanine Green dye combined with near-infrared visualization to allow surgeons to view anatomical details beyond the visible spectrum, supporting clearer identification of essential HPB structures during minimally invasive procedures. For instance, in February 2024, CMR Surgical, a UK-based surgical robotics company, introduced the vLimeLite fluorescence imaging system integrated into its Versius Plus robotic platform. The system provides dual visualization modes, including full-color overlay or greyscale, along with selectable ICG color options in green or cyan, enabling surgeons to assess blood flow, vessel integrity, and biliary anatomy with greater clarity during HPB surgical procedures.
In February 2023, Olympus Corporation, a Japan-based medical technology company, agreed to acquire Taewoong Medical Co., Ltd. for approximately $370 million. Through this acquisition, Olympus seeks to reinforce its gastrointestinal EndoTherapy portfolio by incorporating advanced gastrointestinal metallic stent technologies, expanding minimally invasive treatment options, and improving patient outcomes. Taewoong Medical Co., Ltd. is a Korea-based company specializing in the manufacture of gastrointestinal metallic stents and other minimally invasive GI therapeutic devices.
Major companies operating in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market are Johnson & Johnson Services Ltd., Medtronic Plc, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, BD CooperSurgical Inc., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Smith & Nephew plc, W.L. Gore & Associates Inc., Cook Medical Inc., CONMED Corporation, Richard Wolf GmbH, CooperSurgical Inc., Medi-Globe GmbH, Thompson Surgical Instruments Inc., Lotus Surgicals Pvt. Ltd., Hobbs Medical Inc., Medorah Meditek Pvt. Ltd.
North America was the largest region in the hepatic-pancreatic-biliary (HPB) surgical device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the HPB surgeries surgical devices market by increasing costs of imported electrosurgical systems, robotic components, visualization equipment, stents, and precision hand instruments used in complex procedures. Hospitals and specialty surgical centers in North America and Europe are most affected due to dependence on imported high-end surgical technologies, while Asia-Pacific faces increased manufacturing and export costs. These tariffs are raising capital investment requirements and slowing equipment upgrades. However, they are also driving localized manufacturing, regional assembly, and innovation in cost-optimized surgical device platforms.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report is one of a series of new reports that provides hepato-pancreatico-biliary (hpb) surgeries surgical devices market statistics, including hepato-pancreatico-biliary (hpb) surgeries surgical devices industry global market size, regional shares, competitors with a hepato-pancreatico-biliary (hpb) surgeries surgical devices market share, detailed hepato-pancreatico-biliary (hpb) surgeries surgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the hepato-pancreatico-biliary (hpb) surgeries surgical devices industry. This hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices are specialized instruments designed for cutting, dissecting, grasping, and suturing tissues in surgical procedures involving the liver (hepato-), pancreas (pancreatic-), and bile ducts (biliary). These devices play a crucial role in performing intricate procedures on these delicate organs.
The main products in the field of hepato-pancreatic-biliary (HPB) surgeries surgical devices include electrosurgery instruments, endoscopes, hand instruments, access instruments, stents, energy/vessel sealing devices, visualization and robotic surgical systems, surgical suture and stapler devices, and fluid management systems. Electrosurgery instruments utilize high-frequency, alternating electric current to generate heat in tissues, enabling various surgical procedures such as cutting, coagulating, desiccating, or fulgurating tissue. These devices find indications in the treatment of conditions such as liver cancer, pancreatic cancer, gallstones, bile duct cancer, cirrhosis, pancreatitis, and cholecystitis. They are commonly used in hospitals, specialty clinics, trauma centers, and ambulatory surgical centers.
The hepato-pancreatico-biliary (HPB) surgeries surgical devices market includes revenues earned by entities by liver surgeries, ultrasonic aspirators, liver retractors, and liver transplantation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepato-pancreatico-biliary (HPB) surgeries surgical devices market also includes sales of visualization and access instruments, trocars, energy devices, and ultrasonic scalpels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Characteristics
3. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Supply Chain Analysis
4. Global Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Trends and Strategies
5. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Analysis of End Use Industries
7. Global Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Total Addressable Market (TAM) Analysis for the Market
9. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Segmentation
10. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Regional and Country Analysis
11. Asia-Pacific Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
12. China Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
13. India Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
14. Japan Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
15. Australia Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
16. Indonesia Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
17. South Korea Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
18. Taiwan Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
19. South East Asia Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
20. Western Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
21. UK Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
22. Germany Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
23. France Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
24. Italy Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
25. Spain Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
26. Eastern Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
27. Russia Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
28. North America Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
29. USA Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
30. Canada Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
31. South America Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
32. Brazil Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
33. Middle East Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
34. Africa Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
36. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Competitive Landscape and Company Profiles
37. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Other Major and Innovative Companies
40. Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hepato-pancreatico-biliary (hpb) surgeries surgical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hepato-pancreatico-biliary (hpb) surgeries surgical devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hepato-pancreatico-biliary (hpb) surgeries surgical devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Electrosurgery Instruments; Endoscope; Hand Instruments; Access Instruments; Stents; Energy/Vessel Sealing Devices; Visualization and Robotic Surgical System; Surgical Suture and Stapler Devices; Fluid Management System2) By Indication: Liver Cancer; Pancreatic Cancer; Gall Stones; Bile Duct Cancer; Cirrhosis; Pancreatitis; Cholecystitis
3) By End User: Hospitals; Specialty Clinics; Trauma Centers; Ambulatory Surgical Centers
Subsegments:
1) By Electrosurgery Instruments: Electrosurgical Generators; Monopolar And Bipolar Electrosurgical Devices; Electrosurgical Pencils And Accessories2) By Endoscope: Rigid Endoscopes; Flexible Endoscopes; Laparoscopes; Video Endoscopes
3) By Hand Instruments: Scissors; Forceps; Graspers; Scalpels
4) By Access Instruments: Trocar And Cannula Systems; Access Ports; Balloon Dilators
5) By Stents: Biliary Stents; Pancreatic Stents; Drug-Eluting Stents
6) By Energy Or Vessel Sealing Devices: Ultrasonic Energy Devices; Radiofrequency Ablation Devices; Hemostatic Devices
7) By Visualization And Robotic Surgical System: Robotic Surgical Systems; High-Definition Visualization Systems; Surgical Cameras
8) By Surgical Suture And Stapler Devices: Absorbable And Non-Absorbable Sutures; Manual And Automated Staplers; Linear Staplers
9) By Fluid Management System: Fluid Warming Systems; Fluid Suction Systems; Drainage Systems
Companies Mentioned: Johnson & Johnson Services Ltd.; Medtronic Plc; KARL STORZ SE & Co. KG; FUJIFILM Holdings Corporation; BD CooperSurgical Inc.; Stryker Corporation; Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; Terumo Corporation; Smith & Nephew plc; W.L. Gore & Associates Inc.; Cook Medical Inc.; CONMED Corporation; Richard Wolf GmbH; CooperSurgical Inc.; Medi-Globe GmbH; Thompson Surgical Instruments Inc.; Lotus Surgicals Pvt. Ltd.; Hobbs Medical Inc.; Medorah Meditek Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices market report include:- Johnson & Johnson Services Ltd.
- Medtronic Plc
- KARL STORZ SE & Co. KG
- FUJIFILM Holdings Corporation
- BD CooperSurgical Inc.
- Stryker Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Olympus Corporation
- Terumo Corporation
- Smith & Nephew plc
- W.L. Gore & Associates Inc.
- Cook Medical Inc.
- CONMED Corporation
- Richard Wolf GmbH
- CooperSurgical Inc.
- Medi-Globe GmbH
- Thompson Surgical Instruments Inc.
- Lotus Surgicals Pvt. Ltd.
- Hobbs Medical Inc.
- Medorah Meditek Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.99 Billion |
| Forecasted Market Value ( USD | $ 7.73 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
